SCHEMBL23723698

SCHEMBL23723698

NC(=O)c1c(N)cc(Br)cc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.48
PARP1 P09874 2/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
GLA P06280 1/20 0.33
AAK1 Q2M2I8 1/20 0.33
GPR35 Q9HC97 1/20 0.33
PLAU P00749 1/20 0.33
MAP2K1 Q02750 3/20 0.32
MAP2K2 P36507 1/20 0.32
IKBKB O14920 1/20 0.31
CHUK O15111 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1317647 0.87 DGAT1 (0.55) DGAT1PARP1HDAC1HDAC6KDM4E
SCHEMBL2039681 0.84 KDM4E (0.41) DGAT1HDAC1HDAC6KDM4EMEN1
SCHEMBL24252415 0.82 DGAT1 (0.39) DGAT1HDAC1HDAC6KDM4EMEN1
SCHEMBL4047607 0.82 DGAT1 (0.50) DGAT1PARP1HDAC1HDAC6KDM4E
SCHEMBL147636 0.79 CES2 (0.39) DGAT1PARP1HDAC1KMT2AMAP2K1
SCHEMBL24619347 0.78 DGAT1 (0.47) DGAT1PARP1MEN1MAPTKMT2A
SCHEMBL29925464 0.78 DGAT1 (0.47) DGAT1PARP1MEN1MAPTKMT2A
SCHEMBL1725337 0.78 DGAT1 (0.47) DGAT1PARP1HDAC1HDAC6MEN1
SCHEMBL16637069 0.78 NOTUM (0.41) DGAT1KDM4EMAPTGLAIKBKB
SCHEMBL8048802 0.76 NMT1 (0.35) DGAT1PARP1KDM4EGLAGPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724436-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING Remix Therapeutics Inc. (US) 2026-04-15 EP disclosed
WO-2024259017-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2024-12-19 WO disclosed
CN-116113632-A Heterocyclic derivative, preparation method and medical application thereof 浙江海正药业股份有限公司 2023-05-12 CN disclosed
EP-4100124-A1 HETEROCYCLIC COMPOUNDS AS DIHYDROOROTATE DEHYDROGENASE INHIBITORS Janssen Biotech, Inc. (US) 2022-12-14 EP disclosed
CN-115427109-A Heterocyclic compounds as dihydroorotate dehydrogenase inhibitors 詹森生物科技公司 2022-12-02 CN disclosed
WO-2022206723-A1 HETEROCYCLIC DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE 浙江海正药业股份有限公司 2022-10-06 WO disclosed
WO-2021156787-A1 HETEROCYCLIC COMPOUNDS AS DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. (US) 2021-08-12 WO disclosed
WO-2021156787-A1 HETEROCYCLIC COMPOUNDS AS DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. (US) 2021-08-12 WO disclosed